Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

VA-045 ameliorates head injury-induced neurological dysfunction

July 21, 1997

No Comments

First report of kappa-opioid agonist efficacy in humans

July 21, 1997

No Comments

FDA clears new indication and new labeling for Zoloft

July 18, 1997

No Comments

New treatment options for ALS

July 18, 1997

No Comments

BDNF shows potential for stroke therapy in rat model

July 18, 1997

No Comments

MS&D continues to pursue antimigraine agents

July 18, 1997

No Comments

Promising preliminary results reported for Interneuron's ischemic stroke treatment

July 17, 1997

No Comments

FDA approves first medical device for epilepsy

July 17, 1997

No Comments

Acetylcholine receptor modulators reported by SIBIA Neurosciences

July 17, 1997

No Comments

Biomedica Foscama discloses adenosine antagonists for depression

July 17, 1997

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Neurology/psychiatric
RSS

VA-045 ameliorates head injury-induced neurological dysfunction

First report of kappa-opioid agonist efficacy in humans

FDA clears new indication and new labeling for Zoloft

New treatment options for ALS

BDNF shows potential for stroke therapy in rat model

MS&D continues to pursue antimigraine agents

Promising preliminary results reported for Interneuron's ischemic stroke treatment

FDA approves first medical device for epilepsy

Acetylcholine receptor modulators reported by SIBIA Neurosciences

Biomedica Foscama discloses adenosine antagonists for depression

Today's news in brief

Today's news in brief

Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal

Proteomics study explores how protein changes influence disease

Abbvie and Simcere enter a $1B T-cell engager deal

Neurology/psychiatric RSS

Neurology/psychiatric
RSS